Gregory Divis

Gregory J.
Divis is currently Chief Executive Officer & Director at Mentari Therapeutics, Inc. since 2026.
Also holds director positions at Mobius Therapeutics LLC and Health eVillages, Inc., and serves as President of Marchem Northeast, Inc. Former roles include Chief Executive Officer & Director at Avadel Pharmaceuticals Plc from 2019 to 2026; President & Chief Executive Officer at AMAG Pharma USA, Inc. from 2011 to 2013; President & Chief Executive Officer at Lumara Health Services Ltd. in 2014; President, Chief Executive Officer & Director at K-V Generic Pharmaceuticals, Inc. from 2010 to 2014; Director at Accella Performance Materials, Inc.; Director at Tolero Pharmaceuticals, Inc. from 2015 to 2017; Independent Director at Jaguar Health, Inc. from 2018 to 2022; Vice President & General Manager-UK & Ireland at Schering-Plough Corp.
USA from 1992 to 2003; President at RB Rubber Products, Inc.; Operating Partner at Linden Manager LLC from 2015 to 2016; VP-Business Development & Life Cycle Management at Sanofi-Aventis U.S.
LLC from 2004 to 2007; Principal at Schering-Plough Ltd.; Chief Commercial Officer & Executive VP at Avadel Management Corp.
Education includes an undergraduate degree from the University of Iowa, conferred in 1988.